论文部分内容阅读
在行经皮冠状动脉介入治疗的糖尿病患者中,abciximab(阿昔单抗)与支架的联合应用已被证明是降低靶血管血运重建(TVR)和死亡率的标准治疗方法。也有证据显示,术前高血糖水平与选择性冠状动脉内支架术后的TVR有关。意大利学者Luca等进一步研究发现,在行选择性冠状动脉内支架术的
In patients undergoing percutaneous coronary intervention, the combined use of abciximab (sc) and stents has been shown to be the standard treatment for lowering target vessel revascularization (TVR) and mortality. There is also evidence that preoperative hyperglycemia is associated with TVR following selective coronary stenting. Further study by Italian scholar Luca et al found that in the case of selective coronary stenting